Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1

Blood

Volumn 112, Issue 3, 2008, Pages 708-710

  Stern, Martin ^a   Ruggeri, Loredana ^b   Capanni, Marusca ^b   Mancusi, Antonella ^b   Velardi, Andrea ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA A23 ANTIGEN; HLA A24 ANTIGEN; HLA A25 ANTIGEN; HLA A32 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; UNCLASSIFIED DRUG; HLA A23; HLA A25; HLA-A23; HLA-A25; HLA-A32 ANTIGEN; LIGAND;

ALLOIMMUNITY; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; CYTOTOXICITY; HISTOCOMPATIBILITY; IMMUNOLOGY; METABOLISM;

CYTOTOXICITY, IMMUNOLOGIC; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA-A ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LIGANDS; RECEPTORS, KIR3DL1; TRANSPLANTATION IMMUNOLOGY;

EID: 50549100480     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-02-137521     Document Type: Article

References (11)

1. Valiante NM, Uhrberg M, Shilling HG, et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity. 1997;7:739-751.
2. Moretta L, Moretta A. Killer immunoglobulin-like receptors. Curr Opin Immunol. 2004;16:626-633.
3. Braud VM, Allan DS, O'Callaghan CA, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 1998;391:795-799.
4. Ruggeri L, Capanni M, Casucci M, et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood. 1999;94:333-339.
5. Leung W, Iyengar R, Turner V, et al. Determinants of antileukemia effects of allogeneic NK cells. J Immunol. 2004;172:644-650.
6. Hsu KC, Keever-Taylor CA, Wilton A, et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood. 2005;105:4878-4884.
7. Cella M, Longo A, Ferrara GB, Strominger JL, Colonna M. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med. 1994;180:1235-1242.
8. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med. 1995;181:1133-1144.
9. Ruggeri L, Capanni M, Mancusi A, et al. Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation. Blood Cells Mol Dis. 2004;33:216-221.
10. Thananchai H, Gillespie G, Martin MP, et al. Cutting edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol. 2007;178:33-37.
11. Braud VM, Allan DS, Wilson D, McMichael AJ. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr Biol. 1998;8:1-10.